Literature DB >> 48709

Letter: Glucagon in pathogenesis of diabetes.

R H Unger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 48709     DOI： 10.1016/s0140-6736(75)91985-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.

Authors:  Kyle W Sloop; Julia Xiao-Chun Cao; Angela M Siesky; Hong Yan Zhang; Diane M Bodenmiller; Amy L Cox; Steven J Jacobs; Julie S Moyers; Rebecca A Owens; Aaron D Showalter; Martin B Brenner; Achim Raap; Jesper Gromada; Brian R Berridge; David K B Monteith; Niels Porksen; Robert A McKay; Brett P Monia; Sanjay Bhanot; Lynnetta M Watts; M Dodson Michael
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 2.  Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?

Authors:  Ellen Conceição-Furber; Tamer Coskun; Kyle W Sloop; Ricardo J Samms
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-25       Impact factor: 6.055

3.  Transplantation of PC1/3-Expressing alpha-cells improves glucose handling and cold tolerance in leptin-resistant mice.

Authors:  Rhonda D Wideman; Sarah L Gray; Scott D Covey; Gene C Webb; Timothy J Kieffer
Journal:  Mol Ther       Date:  2008-10-21       Impact factor: 11.454

4.  Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.

Authors:  Xi Chen; Enrique Maldonado; Ralph A DeFronzo; Devjit Tripathy
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

5.  Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion.

Authors:  Elisa Vergari; Jakob G Knudsen; Reshma Ramracheya; Albert Salehi; Quan Zhang; Julie Adam; Ingrid Wernstedt Asterholm; Anna Benrick; Linford J B Briant; Margarita V Chibalina; Fiona M Gribble; Alexander Hamilton; Benoit Hastoy; Frank Reimann; Nils J G Rorsman; Ioannis I Spiliotis; Andrei Tarasov; Yanling Wu; Frances M Ashcroft; Patrik Rorsman
Journal:  Nat Commun       Date:  2019-01-11       Impact factor: 14.919
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.